Nicotinic acetylcholine receptors in neonatal motoneurons are regulated by axotomy: An electrophysiological and immunohistochemical study in human Bcl-2 transgenic mice

Neuroscience

Volumn 100, Issue 3, 2000, Pages 589-597

  Zaninetti, M ^a   Dubois Dauphin, M ^b   Lindstrom, J ^c   Raggenbass, M ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dihydro erythroidine; Facial nucleus; Methyllycaconitine; Motoneuron degeneration; Whole cell recordings

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ATROPINE; EPIBATIDINE; METHYLLYCACONITINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERAGE; BRAIN SLICE; BRAIN STEM; CONTROLLED STUDY; FACIAL NERVE NUCLEUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOTONEURON; MOUSE; NERVE DEGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TRANSGENIC MOUSE;

ANIMAL; ANIMALS, NEWBORN; AXOTOMY; ELECTROPHYSIOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CHOLINERGIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034721545     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00303-1     Document Type: Article

References (29)

1. Alberi S., Raggenbass M., de Bilbao F., Dubois-Dauphin M. Axotomized neonatal motoneurons overexpressing the bcl2 proto-oncogene retain functional electrophysiological properties. Proc. natn. Acad. Sci. USA. 93:1996;3978-3983.
2. Bertrand D., Bertrand S., Ballivet M. Pharmacological properties of the homomeric α7 receptor. Neurosci. Lett. 146:1992;87-90.
3. Buisson B., Gopalakrishnan M., Arneric S.P., Sullivan J.P., Bertrand D. Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J. Neurosci. 16:1996;7880-7891.
4. Carlson N.G., Bacchi A., Rogers S.W., Gahring L.C. Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway. J. Neurobiol. 35:1998;29-36.
5. Cleveland D.W. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron. 24:1999;515-520.
6. de Bilbao F., Dubois-Dauphin M. Time course of axotomy-induced apoptotic cell death in facial motoneurons of neonatal wild type and bcl-2 transgenic mice. Neuroscience. 71:1996;1111-1119.
7. Drasdo A., Caulfield M., Bertrand D., Bertrand S., Wonnacott S. Metyllycaconitine: a novel nicotinic antagonist. Molec. Cell Neurosci. 3:1992;237-243.
8. Dubois-Dauphin M., Frankowski H., Tsujimoto Y., Huarte J., Martinou J.C. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. natn. Acad. Sci. USA. 91:1994;3309-3313.
9. Flood D.G., Reaume A.G., Gruner J.A., Hoffman E.K., Hirsch J.D., Lin Y.G., Dorfman K.S., Scott R.W. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am. J. Path. 155:1999;663-672.
10. Hill J.A. Jr., Zoli M., Bourgeois J.P., Changeux J.P. Immunocytochemical localization of a neuronal nicotinic receptor: the β2-subunit. J. Neurosci. 13:1993;1551-1568.
11. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci. 22:1999;555-561.
12. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α7-neuronal receptors and neuronal CNS receptors. Brain Res. 765:1997;135-140.
13. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A. Stimulation of α4β2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 792:1998;331-334.
14. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Ion Channels. 4:1996;377-450.
15. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73:1999;1635-1640.
16. Marutle A., Warpman U., Bogdanovic N., Lannfelt L., Nordberg A. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. J. Neurochem. 72:1999;1161-1169.
17. Messi M.L., Renganathan M., Grigorenko E., Delbono O. Activation of α7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons. Fedn Eur. biochem. Socs Lett. 411:1997;32-38.
18. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic α7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol. (Lond.). 491:1996;151-161.
19. Raggenbass M., Alberi S., Zaninetti M., Pierson P., Dreifuss J.J. Vasopressin and oxytocin action in the brain: cellular neurophysiological studies. Prog. Brain Res. 119:1998;263-273.
20. Raggenbass M., Lindstrom J., Dubois-Dauphin M., Zaninetti M. Neonatal axotomy causes disappearance of nicotinic acetylcholine receptors in motoneurons of Bcl-2 transgenic mice. Soc. Neurosci. Abstr. 25:1999;1491.
21. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
22. Senba E., Simmons D.M., Wada E., Wada K., Swanson L.W. RNA levels of neuronal nicotinic acetylcholine receptor subunits are differentially regulated in axotomized facial motoneurons: an in situ hybridization study. Brain Res. molec. Brain Res. 8:1990;349-353.
23. 3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience. 94:1999;685-696.
24. Umemiya M., Araki I., Kuno M. Electrophysiological properties of axotomized facial motoneurones that are destined to die in neonatal rats. J. Physiol. (Lond.). 462:1993;661-678.
25. Wang F., Nelson M.E., Kuryatov A., Olale F., Cooper J., Keyser K., Lindstrom J. Chronic nicotine treatment up-regulates human α3 β2 but not α3 β4 acetylcholine receptors stably transfected in human embryonic kidney cells. J. biol. Chem. 273:1998;28,721-28,732.
26. Wevers A., Monteggia L., Nowacki S., Bloch W., Schutz U., Lindstrom J., Pereira E.F., Eisenberg H., Giacobini E., de Vos R.A., Steur E.N., Maelicke A., Albuquerque E.X., Schroder H. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur. J. Neurosci. 11:1999;2551-2565.
27. Zaninetti M., Tribollet E., Bertrand D., Raggenbass M. Presence of functional neuronal nicotinic acetylcholine receptors in brainstem motoneurons of the rat. Eur. J. Neurosci. 11:1999;2737-2748.
28. Zoli M., Lena C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18:1998;4461-4472.
29. Zoli M., Picciotto M.R., Ferrari R., Cocchi D., Changeux J.P. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. Eur. molec. Biol. Org. J. 18:1999;1235-1244.